Yong Liu

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Venues

British journal of clinical pharmacology

Biomedical chromatography : BMC

Journal of oncology

Environmental toxicology

Dalian University of Technology

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dalian University of Technology Jan 01 2014

China

Dr. & Prof.

Publications

Shichao Xiao, Hang Yin, Xin Lv, Zhen Wang, Lili Jiang, Yangliu Xia, Yong Liu
Efficacy and safety of androgen receptor inhibitors for treatment of advanced prostate cancer: A systematic review and network meta-analysis. British journal of clinical pharmacology 90 (9) (2024)
Shichao Xiao, Hang Yin, Xin Lv, Zhen Wang, Lili Jiang, Yangliu Xia, Yong Liu
Efficacy and safety of androgen receptor inhibitors for treatment of advanced prostate cancer: A systematic review and network meta-analysis. British journal of clinical pharmacology (2024)
Shichao Xiao, Hang Yin, Xin Lv, Zhen Wang, Lili Jiang, Yangliu Xia, Yong Liu
Efficacy and safety of androgen receptor inhibitors for treatment of advanced prostate cancer: A systematic review and network meta-analysis. British journal of clinical pharmacology 90 (9) (2024)
Zhe Wang, Xiaoyu Wang, Zhen Wang, Xiaoyu Fan, Mingrui Yan, Lili Jiang, Yangliu Xia, Jun Cao, Yong Liu
Prediction of Drug-Drug Interaction Between Dabrafenib and Irinotecan via UGT1A1-Mediated Glucuronidation. European journal of drug metabolism and pharmacokinetics 47 (3) (2022)
Mongameli B Dlamini, Shibo Bao, Zeyun Gao, Junjie Mei, Hong Ge, Liping Jiang, Chengyan Geng, Qiujuan Li, Xiaoxia Shi, Yong Liu, Jun Cao
Curcumin attenuates Cr (VI)-induced cell growth and migration by targeting autophagy-dependent reprogrammed metabolism. Journal of biochemical and molecular toxicology 36 (11) (2022)
Mingrui Yan, Xiaoyu Fan, Hongyanhua Si, Xiaoyu Wang, Zhe Wang, Zhen Wang, Xin Lv, Hang Yin, Yanyan Jia, Lili Jiang, Yangliu Xia, Yong Liu
Association between gene polymorphism and adverse effects in cancer patients receiving docetaxel treatment: a meta-analysis. Cancer chemotherapy and pharmacology 89 (2) (2022)
Shujuan Wang, Xiaoyu Wang, Zhe Wang, Zhen Wang, Lili Jiang, Jing Liu, Jingjing Wu, Yong Liu
Highly Sensitive and Selective Detection of Cytochrome P450 46A1 Activity by UPLC-MS/MS Method. Biomedical chromatography : BMC (2021)
Teng Mu, Tingguang Chu, Wenxin Li, Qianze Dong, Yong Liu
N1, N12-Diacetylspermine Is Elevated in Colorectal Cancer and Promotes Proliferation through the miR-559/CBS Axis in Cancer Cell Lines. Journal of oncology 2021 (2021)
Lili Jiang, Zhongmin Zhang, Zhen Wang, Yong Liu
Discovery of novel potential KIT inhibitors for the treatment of gastrointestinal stromal tumor. Open life sciences 16 (1) (2021)
Mongameli B Dlamini, Zeyun Gao, null Hasenbilige, Liping Jiang, Chengyan Geng, Qiujuan Li, Xiaoxia Shi, Yong Liu, Jun Cao
The crosstalk between mitochondrial dysfunction and endoplasmic reticulum stress promoted ATF4-mediated mitophagy induced by hexavalent chromium. Environmental toxicology 36 (6) (2021)
Hang Yin, Zhe Wang, Xiaoyu Wang, Xin Lv, Xiaoyu Fan, Mingrui Yan, Yanyan Jia, Lili Jiang, Jun Cao, Yong Liu
Inhibition of human UDP-glucuronosyltransferase enzyme by Dabrafenib: Implications for drug-drug interactions. Biomedical chromatography : BMC 35 (11) (2021)
Zhe Wang, Xiaoyu Wang, Yaqin Jia, Hang Yin, Yuyi Feng, Lili Jiang, Jun Cao, Yong Liu
Inhibition of human UDP-glucuronosyltransferase enzymes by midostaurin and ruxolitinib: implications for drug-drug interactions. Biopharmaceutics & drug disposition 41 (6) (2020)
Lili Jiang, Zhen Wang, Xiaoyu Wang, Shujuan Wang, Jun Cao, Yong Liu
Exploring the inhibitory mechanism of piceatannol on α-glucosidase relevant to diabetes mellitus. RSC advances 10 (8) (2020)

Yong Liu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yong Liu